Kinetic segregation gated Chimeric Antigen Receptors
Chimeric Antigen Receptor (CAR) T cell therapy has had unprecedented success in the treatment of haematological malignancies, this is especially true in clinical trials targeted against CD19 for the treatment of paediatric Acute Lymphoblastic Leukaemia (ALL) and Chronic Lymphocytic Leukaemia (CLL)....
Main Author: | |
---|---|
Published: |
University College London (University of London)
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.746389 |